Pre-Switch Announces Cross-Platform Soft-Switching Technology Using Artificial Intelligence
Pre-Switch, Inc., the world’s premier supplier of soft switching technology, today introduced Pre-Flex™ Technology, an embedded AI (Artificial Intelligence) controller IC (Integrated Circuit) which effectively eliminates transistor switching losses in hard-switched architectures for virtually any power converter topology. Pre-Flex dramatically reduces cost, size and weight, while increasing efficiency and reliability of power converters in the server, solar, wind, EV, traction and motor drive markets.
Pre-Flex technology learns and adapts “in-system,” on a cycle-by-cycle basis, to reliably force resonant soft-switch across changing loads, input voltages, temperatures and manufacturing tolerances. The technology has proven efficiencies greater than those of five-level topologies at a fraction of the cost and complexity. Pre-Flex also significantly lowers EMI (Electromagnetic interference) and dramatically decreases dV/dt for any switch type. Pre-Flex enables Silicon carbide-like performance for low-cost IGBTs, and allows SiC- and GaN-based topologies to switch up to 20x faster than they do today. Built into the architecture are innovative cycle-by-cycle safety features and communications that were never possible before. Pre-Flex has switched 900V Wolfspeed SiC MOSFETs up to 1MHz, and 650V Infineon IGBTs at over 100 kHz with unprecedented efficiencies. The technology presently scales from 1 KW to above gigawatts.
“We have removed the biggest barrier to advancing the power conversion industry,” said Bruce Renouard, chief executive officer of Pre-Switch, Inc. “Our technology enables simple, reliable and cost-effective forced resonant soft-switching on any topology.”
Pre-Switch is working with development partners interested in leading their respective industries by designing their next-generation power converters with Pre-Flex technology.
“By significantly reducing IGBT switching losses without increasing dV/dt, Pre-Switch is creating a possibility to redefine our VFD motor drives to be smaller and more efficient without being harmful to motor insulation and bearings,” said Adalberto Jose Rossa, Drives R&D manager of WEG Drives & Controls. “We are investigating this technology, and initial test results at double-pulse and at short-circuit conditions have inspired us to test a complete drive with Pre-Switch technology. We look forward to analyzing reliability data of the system under real motor load conditions.”
“The higher switching frequencies enabled by Pre-Switch are able to provide a lower motor current ripple,” said Carlos Afonso Hümmelgen, Drives R&D coordinator from WEG Drives & Controls. “Lower motor current ripple yields reduced motor harmonic losses, and increased motor and system efficiency.”
Pre-Switch will be at PCIM Europe 2018 in Nuremberg, Germany, at booth 6-147 in Hall 6.
About Pre-Switch, Inc.
Pre-Switch, Inc. is a Silicon Valley power architecture company that develops embedded AI technology to solve complex timing problems associated with forced resonance soft-switching in power conversion. The company was founded by industry experts in power semiconductors, power systems, robotics, and artificial intelligence. Pre-Flex technology is patent pending globally. For more information, visit www.pre-switch.com/.
Pre-Switch®, the Pre-Switch logo and other trademarks or service names are the trademarks of Pre-Switch, Inc. or of their respective owners.
for Pre-Switch, Inc.
Christian Zdebel, 484-788-2384
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
American Express Wins Major Antitrust Lawsuit25.6.2018 18:05 | Pressemelding
American Express (NYSE:AXP) issued the following statement today from Chairman and CEO Stephen J. Squeri regarding the U.S. Supreme Court’s decision in the Department of Justice’s antitrust lawsuit: “The Court’s decision is a major victory for consumers and for American Express. “This was a long battle, but well worth the fight because important issues were at stake: consumer choice, fair market competition, and the ability to deliver innovative products and services to our customers, both consumers and merchants. “As the Supreme Court stated today, ‘…Amex’s business model has stimulated competitive innovations in the credit-card market, increasing the volume of transactions and improving the quality of the services.’ “Since this case started eight years ago, we have significantly expanded the network of merchants who willingly accept American Express, and have seen merchant satisfaction steadily increase. We have also broadened the range of benefits, services and experiences that buil
Synteract Announces Collaboration with International Children’s Advisory Network iCAN Research25.6.2018 17:03 | Pressemelding
Synteract, an innovative contract research organization (CRO) providing full, phase I-IV services enabling drug development companies to bring new medicines to market, has signed a memo of understanding to partner with the International Children’s Advisory Network (iCAN). A worldwide consortium of children’s advisory groups, iCAN is dedicated to giving children and families a voice in health, medicine, research, and innovation by increasing education about the importance of children’s involvement. Synteract is a sponsor at the 2018 iCAN Research Summit in Edinburgh, Scotland, UK, July 8-13, 2018 and will hold two interactive plenary seminar sessions at the event. With chapters across the U.S. and worldwide, iCAN partners with local children’s hospitals and addresses the needs of pediatric clinical research and healthcare and advocates for patients worldwide. In partnering with iCAN, Synteract will expand its access to children and families familiar with clinical research. iCAN will sup
GA-ASI to Fly First Trans-Atlantic Flight of a MALE RPA25.6.2018 16:55 | Pressemelding
On July 10-11, General Atomics Aeronautical Systems, Inc. (GA-ASI) plans to make the first-ever trans-Atlantic flight of a Medium-altitude, Long-endurance (MALE) Remotely Piloted Aircraft (RPA). GA-ASI’s company-owned MQ-9B SkyGuardian RPA is scheduled to fly from the company’s Flight Test and Training Center in Grand Forks, North Dakota, USA, to Royal Air Force (RAF) Fairford in Gloucestershire, UK. The aircraft will then be on static display July 13-15 for the Royal International Air Tattoo (RIAT) airshow being held at RAF Fairford. The flight and display will commemorate the RAF’s centenary celebration (RAF100). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005946/en/ GA-ASI’s company-owned MQ-9B SkyGuardian RPA is scheduled to fly from the company’s Flight Test and Training Center in Grand Forks, North Dakota, USA, to Royal Air Force (RAF) Fairford in Gloucestershire, UK. The aircraft will then be on static displa
Quadient Announces General Availability of Quadient Inspire R1225.6.2018 14:30 | Pressemelding
www.quadient.com : Quadient, the award-winning leader in Customer Communications Management (CCM), announced the general availability of its newest release, Quadient Inspire R12, which includes the new Digital Advantage Suite. The updated version of Quadient Inspire is designed to give customers and partners greater control over the systems and processes used to drive consistent communications across all channels with an emphasis on digital experiences. With Inspire R12, users design omni-channel communications in days rather than months with a simple, modern and comprehensive platform. The solution makes it possible to change designs and test for all channels in minutes, with fully integrated tracking and approval processes built in. Additionally, R12 integrates all parts of the communications process from linking journey maps to communications, postal sorting, address, phone and email verifications, email delivery, SMS delivery, mail delivery tracking, and production monitoring to re
The Dementia Discovery Fund Raises $350 Million25.6.2018 13:00 | Pressemelding
The Dementia Discovery Fund (DDF) today announces the completion of its fundraising, with £250 million ($350 million at the time of completion) raised from an influential group of strategic investors committed to developing new medicines for dementia. The goal was met today with a new investment of $60 million from US AARP, the global nonpartisan organisation dedicated to empowering Americans 50 and older to choose how they live as they age. The fundraising far exceeded its initial target of $200 million (£130 million), making it the first and largest venture fund focused entirely on discovering and developing novel therapies for dementia, including Alzheimer’s disease. The DDF makes early stage venture capital investments to develop novel disease-modifying therapeutics for all forms of dementia. The fund is managed by SV Health and was formed through the collaboration of leading pharmaceutical companies (Biogen, Eli Lilly and Company, GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and
Professor Thierry Philip Takes Office as OECI President25.6.2018 12:22 | Pressemelding
Professor Thierry Philip, President of the Institut Curie, has been elected President of the Organisation of European Cancer Institutes ( OECI ) for a three-year term. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005600/en/ Pr Thierry Philip (Photo: Business Wire) At the end of June 2018, Professor Philip, an oncologist and pediatrician, will take over as head of this European organization, which brings together 90 institutes and university centers and whose mission is fully devoted to cancer. This European non-governmental, non-profit organization aims to promote cooperation between its members or associate members and pursues a triple objective: to provide cancer patients in Europe with equal access to high-quality care; to assist European institutes with the implementation of a quality system for oncology care; to promote and accelerate the progress of translational research. In this regard, half of the 90 OECI ce